Abexinostat
- Generic Name
- Abexinostat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H23N3O5
- CAS Number
- 783355-60-2
- Unique Ingredient Identifier
- IYO470654U
- Background
Abexinostat has been used in trials studying the treatment of Sarcoma, Lymphoma, Leukemia, Lymphocytic, and Hodgkin Disease, among others. It is a novel, broad-spectrum hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potential antineoplastic activity.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath